First human clinical trial for nicotinamide riboside
(University of Iowa Health Care) In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite that is critical for cellular energy production and protection against stress and DNA damage.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: International Medicine & Public Health | Vitamin B3